Erik Meijer

Erik Meijer is a PhD student in the Comp3D group. He holds an MSc in Bio-Pharmaceutical Sciences, specializing in Computational Drug Development, from Leiden University. His research focuses on the development and interpretation of large-scale bioactivity prediction models.